QA: Dynavax Technologies CORP in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2016_Dynavax_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001029142, Dynavax Technologies CORP

  xvar xval
0 AssetsCurrent 199,946,000
1 IntangibleAssetsNetIncludingGoodwill 2,043,000
2 PropertyPlantAndEquipmentNet 13,804,000
3 remainder_Assets 840,000
4 LiabilitiesCurrent 28,785,000
5 LiabilitiesNoncurrent 769,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 24,057,585
9 ResearchAndDevelopmentExpense 86,957,071
10 remainder_Expenses 588,372
11 remainder_Revenues 6,252,235
12 remainder_NetIncome 317,744
13 remainder_ComprehensiveNetIncome -1,292,762
  yvar yval
0 Assets 216,633,000
1 Liabilities 29,554,000
2 Expenses 111,603,028
3 Revenues 6,252,235
4 StockholdersEquity 187,079,000
5 NetIncome -105,033,049
6 ComprehensiveNetIncome -105,679,430
7 BaseVar 182,826,384
8 EconomicCapitalRatiobeforeLimitedLiability 2.45
9 EconomicCapitalRatio 3.33

Edgar->Model Mapping

Feature Distribution

Change over Time